Start Your Zantac Lawsuit Today
If you’ve taken Zantac (Ranitidine) and subsequently developed cancer, our assembled team of attorneys can help you get the justice and compensation you rightfully deserve. The attorneys we work with have handled a growing number of lawsuits involving pharmaceutical toxins. They’ll fight to ensure you receive the maximum money damages possible. It’s time to hold the drug makers accountable for their blatant willingness to put profit before people’s health.
Zantac and Cancer – What You Need to Know
Antacid drugs are among some of the most commonly taken drugs in the USA. One of these drugs, Zantac (Ranitidine in its generic form), which is regularly taken by millions, has been recently identified as having a cancer-causing ingredient nearly 3,000 times more than the FDA’s recommended daily limit.
Growing evidence suggests that pharmaceutical company Sanofi and Boehringer Ingelheim, manufacturer of Zantac, allegedly concealed Zantac’s cancer link despite knowledge of its potential cancer-causing effects. Meanwhile the company generated sales of over $1 billion in profit.
Past users of Zantac are now filing Zantac lawsuits in order to hold Sanofi and Boehringer Ingelheim accountable for blatant disregard for the health of their consumers and endangering the lives of countless numbers of people.
Zantac Recall 2019
The FDA lists regular Zantac recall updates.
What is Zantac?
Zantac (Ranitidine), is a very popular medication that has been sold worldwide since the early 1980s. It is part of a group of drugs called histamine-2 blockers and is designed to reduce the amount of acid produced by the stomach.
It is commonly used to treat a number of common stomach acid-related issues including:
- Gastroesophageal Reflux Disease (GERD)
- Peptic Ulcers
- Zollinger–Ellison Syndrome
- Upper GI bleeding
Dosage for Zantac ranges between 75 and 150 mg, while some patients may have taken a once daily Zantac 300 mg dosage. Zantac has been available both by prescription and over the counter (OTC) at lower doses, where it is commonly used as a treatment for heartburn.
Does Zantac Cause Cancer?
The Environmental Protection Agency (EPA) also identified NDMA as belonging to a family of chemicals called N-Nitro-samines, which they describe as “potent carcinogens”.
Carcinogenic effects of NDMA exposure potentially include:
- Stomach Cancer
- Liver Cancer
- Kidney Cancer
- Prostate Cancer
- Colon Cancer
- Colorectal Cancer
- Prostate Cancer
- Esophageal Cancer
- Pancreatic Cancer
- Bladder Cancer
Fighting To Win Your Zantac Lawsuit
- Pain and suffering
- Wages or future earnings
- Medical bills
- Funeral costs
- Companionship / Support in cases of wrongful death
Free Zantac Case Review With Our Law Firm
To ensure you have the best chance of winning your case, you need lawyers with experience in winning defective drug cases. Our dedicated team of Zantac attorneys will work hard to demand the maximum settlement possible for you.
Get a no-cost claim review to see if you are eligible for compensation. Call Isaacs and Isaacs 24/7 at 800-800-8888 or complete the form below.
Common Zantac Lawsuit FAQ’s
Zantac (Ranitidine in its generic form) has been identified as containing a cancer-causing ingredient nearly 3,000 times more than the FDA’s recommended daily limit.
Timeline of Zantac recall:
- April 1, 2020: FDA announces its request for all manufacturers to withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.
- January 8, 2020: FDA alerts patients and health care professionals to Mylan’s voluntary recall of nizatidine.
- November 1, 2019: Novartis and Apotex announce recall of all generic ranitidine products they sell in the US.
- October 1, 2019: CVS and Walgreens announce they will be pulling Zantac and generic versions of ranitidine.
- September 13, 2019 – FDA announces some Ranitidine medications contain N-nitrosodimethylamine (NDMA).
The World Health Organization classifies chemicals contained in Zantac and some generic versions as a probable human carcinogen. They note that exposure to high amounts of N-nitrosodimethylamine (NDMA) has links to causing colorectal or gastric cancer.